We are very pleased to announce the first keynote. Holger Kissel, Vice President Business Alliances of BioNTech will open the 2nd conference day (April 29) with his presentation. As a result of the pandemic, BioNTech has become a globally known flagship of the German biotechnology industry virtually overnight. The BioNTech vaccine is key to overcoming the Corona crisis. The company has achieved something unique in many respects: for the first time ever, an mRNA-based vaccine was brought to market approval. And it did so with an incredible effort within just a few months. Holger Kissel will tell us more about the company’s “Lightspeed” journey and its challenges and important milestones. We are looking forward to some exciting insights.